Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:YMAB
DateTimeSourceHeadlineSymbolCompany
10/01/202514:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
10/01/202514:26GlobeNewswire Inc.Correcting & Replacing – Y-mAbs Provides Strategic Business Update and 2025 PrioritiesNASDAQ:YMABY mAbs Therapeutics Inc
10/01/202512:35GlobeNewswire Inc.Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business UnitNASDAQ:YMABY mAbs Therapeutics Inc
10/01/202512:05GlobeNewswire Inc.Y-mAbs Provides Strategic Business Update and 2025 PrioritiesNASDAQ:YMABY mAbs Therapeutics Inc
23/12/202412:30GlobeNewswire Inc.Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:YMABY mAbs Therapeutics Inc
07/12/202417:00GlobeNewswire Inc.Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
27/11/202412:35GlobeNewswire Inc.Y-mAbs to Participate at Citi’s 2024 Global Healthcare ConferenceNASDAQ:YMABY mAbs Therapeutics Inc
14/11/202421:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:YMABY mAbs Therapeutics Inc
08/11/202412:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:YMABY mAbs Therapeutics Inc
08/11/202411:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
08/11/202411:35GlobeNewswire Inc.Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
04/11/202413:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
04/11/202412:35GlobeNewswire Inc.Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in JapanNASDAQ:YMABY mAbs Therapeutics Inc
25/10/202411:05GlobeNewswire Inc.Y-mAbs Announces Third Quarter 2024 Conference Call and WebcastNASDAQ:YMABY mAbs Therapeutics Inc
01/10/202411:05GlobeNewswire Inc.Y-mAbs to Participate in Upcoming Investor Conferences in OctoberNASDAQ:YMABY mAbs Therapeutics Inc
20/09/202420:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
20/09/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
18/09/202400:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
17/09/202421:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
13/09/202420:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
06/09/202411:30GlobeNewswire Inc.Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer ResearchNASDAQ:YMABY mAbs Therapeutics Inc
03/09/202421:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
03/09/202412:32GlobeNewswire Inc.Y-mAbs to Participate in Upcoming Investor Conferences in SeptemberNASDAQ:YMABY mAbs Therapeutics Inc
30/08/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
28/08/202421:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
27/08/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
26/08/202420:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
12/08/202411:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:YMABY mAbs Therapeutics Inc
12/08/202410:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
12/08/202410:30GlobeNewswire Inc.Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMAB